TriVascular Technologies, Inc. to Present at the Canaccord Genuity Growth Conference
July 29, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., July 29, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that its...
TriVascular Technologies, Inc. to Hold 2015 Second Quarter Financial Results Conference Call on August 4, 2015
July 21, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., July 21, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that the...
TriVascular Technologies, Inc. Announces FDA Approval of Ovation iX(TM) Iliac Stent Graft
June 15, 2015 08:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., June 15, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today that the U.S. Food and Drug Administration (FDA) has approved the Ovation...
TriVascular Technologies, Inc. Reports First Quarter Financial Results
May 05, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today reported financial results...
TriVascular Technologies, Inc. to Hold 2015 First Quarter Financial Results Conference Call on May 5
April 22, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that the...
TriVascular Technologies, Inc. Announces Preliminary First Quarter Revenue Results
April 08, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that based on...
TriVascular Technologies, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results
March 03, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today reported financial...
TriVascular Technologies, Inc. to Hold 2014 Fourth Quarter and Year-End Financial Results Conference Call on March 3
February 18, 2015 08:30 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the Company will release 2014 fourth quarter and year-end financial results...
TriVascular Technologies, Inc. to Participate in Upcoming Investor Conferences
January 28, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Jan. 28, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that its...
TriVascular Technologies, Inc. Announces Preliminary Results for Fourth Quarter and Full Year 2014 and Provides 2015 Outlook
January 12, 2015 08:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), in anticipation of investor meetings during the week of January 12, is announcing preliminary...